A CROSS-SECTIONAL SURVEY-BASED INVESTIGATION ON KNOWLEDGE, ATTITUDE, AND PRACTICE OF PHARMACOVIGILANCE AMIDST HEALTHCARE PROVIDERS OF JORHAT CITY, ASSAM

NAYAN DEY; SAHID AZIZ; NYAGI RIBA; RAJESH JESUDASAN

doi:10.22159/ijpps.2025v17i1.51703

Authors

NAYAN DEY School of Pharmacy, the Assam Kaziranga University, Jorhat, Assam, India https://orcid.org/0009-0003-5780-7999
SAHID AZIZ Department of Pharmacology, Jorhat Medical College and Hospital, Assam, India
NYAGI RIBA Department of Pharmacology, School of Pharmacy, the Assam Kaziranga University, Jorhat, Assam, India
RAJESH JESUDASAN Department of Pharmaceutics, School of Pharmacy, The Assam Kaziranga University, Jorhat, Assam, India

DOI:

https://doi.org/10.22159/ijpps.2025v17i1.51703

Keywords:

Adverse drug reaction, Pharmacovigilance, Health care providers' attitudes, Practices, and knowledge

Abstract

Among the main causes of increasing rates of sickness, death rates, and medical cost expenses is an Adverse Drug Reaction (ADRs). To guarantee improved patient safety, the Pharmacovigilance Programme of India (PvPI) encourages every healthcare worker to report possible ADRs. However, current data indicates that suspected ADRs are not being reported enough. In light of this, the current study was carried out to gauge the healthcare provider’s Knowledge, Attitude, and Practice (KAP) on pharmacovigilance and to investigate the causes behind the underreporting of suspected ADRs in Jorhat City, Assam.

Methods: KAP of HCPs, comprising pharmacists, physicians as well as nurses, about pharmacovigilance is the subject of this observational investigation with a cross-section, carried out at Jorhat City, Assam. The pretested and peer-reviewed multiple-choice test consisting of 30 queries was utilized to assess the knowledge (1-16), attitude (17-22), and practice (23-30) between 61 HCPs of the city and the responses were collected after 30 minutes from each HCP. Utilizing Microsoft Excel software, data were analyzed and expressed as a percentage.

Results: 53 responses-21 pharmacists, 20 nurses, and 20 doctors-were obtained from 61 surveys. Although the Healthcare Professionals demonstrated a good attitude (73.38%) and adequate knowledge, they did not perform pharmacovigilance for several reasons, the primary one being training on ADR reporting (34.33%), didn’t send any suspected ADR report to the manufacturer (44.17%), haven’t seen pharmacist reporting ADR (36.67%) and also due to not available of ADR Reporting form (25.11%).

Conclusion: The HCPs exhibited a good attitude. Still, the modification from attitude to knowledge and practice wasn't sufficient. Expertise and training can be significantly raised by making ADR reporting forms more accessible and adopting accessible techniques like instruction and guidance on reporting adverse drug reactions.

Downloads

Download data is not yet available.

References

Schurig AM, Böhme M, Just KS, Scholl C, Dormann H, Plank-Kiegele B, Seufferlein T, Gräff I, Schwab M, Stingl JC. Adverse Drug Reactions (ADR) and Emergencies. DtschArztebl Int. 2018 Apr 13;115(15):251-258. doi: 10.3238/arztebl.2018.0251. PMID: 29735005; PMCID: PMC5949373.

Ahmad, Akram; Patel, Isha1; Balkrishnan, Rajesh1; Mohanta, G. P.; Manna, P. K. An evaluation of knowledge, attitude, and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study. Perspectives in Clinical Research 4(4):p 204-210, Oct-Dec 2013. | DOI: 10.4103/2229-3485.120168

Dhikav, Vikas, Sindhu Singh, and K. S. Anand. "Adverse drug reaction monitoring in India." J Indian AcadClin Med 5.1 (2004): 27-33.

Hussain R, Hassali MA, Hashmi F, Akram T. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey. J Pharm Policy Pract. 2021 Jan 4;14(1):5. doi: 10.1186/s40545-020-00287-3. PMID: 33397478; PMCID: PMC7784002.

Guidance Document for Spontaneous Adverse Drug Reaction Reporting version 1.0. Indian Pharmacopoeia Commission. National Coordination Centre- Pharmacovigilance Programme of India. Ministry of Health and Family Welfare, Government of India; 2014.

Agarwal, Monika; Ahmed, Jamshed; Roy, Vandana. Knowledge, Attitude, and Practice About Pharmacovigilance Among Healthcare Providers of a Tertiary Care Teaching Hospital in New Delhi (India). MAMC Journal of Medical Sciences 3(3):p 146-151, Sep–Dec 2017. | DOI: 10.4103/mamcjms.mamcjms_31_17

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Indian J Pharmacol. 2015 Jan-Feb;47(1):65-71. doi: 10.4103/0253-7613.150344. PMID: 25821314; PMCID: PMC4375822.

Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993 Jul-Aug;27(7-8):832-40. doi: 10.1177/106002809302700702. PMID: 8364259.

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital--their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003 Dec;12(8):687-92. doi 10.1002/pds.871. PMID: 14762985.

World Health Report, 2006. Available at http://www.who.int/whr/2006/en/ accessed on 28th August 2009.

Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, Grahame-Smith DG. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol. 1996 Oct;42(4):423-9. doi: 10.1046/j.1365-2125.1996.04376.x. PMID: 8904613; PMCID: PMC2042689.

Prakash, Shiv. Pharmacovigilance in India. Indian Journal of Pharmacology 39(3):p 123, May–Jun 2007. | DOI: 10.4103/0253-7613.33430

Klopotowska JE, Wierenga PC, Smorenburg SM, Stuijt CC, Arisz L, Kuks PF, Dijkgraaf MG, Lie-A-Huen L, de Rooij SE; WINGS study group. Recognition of adverse drug events in older hospitalized medical patients. Eur J ClinPharmacol. 2013 Jan;69(1):75-85. doi: 10.1007/s00228-012-1316-4. Epub 2012 Jun 7. PMID: 22673927; PMCID: PMC3536996.

Gupta R, Malhotra A, Malhotra P. A study on determinants of underreporting of adverse drug reactions among resident doctors. Int J Res Med Sci 2018;6:623-7.

Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: knowledge, attitude, and practices of medical students and prescribers. Natl Med J India. 2002 Jan-Feb;15(1):24-6. PMID: 11855588.

Vora MB, Paliwal NP, Doshi VG, Barvaliya MJ, Tripathi CB. Knowledge of adverse drug reactions and pharmacovigilance activity among the undergraduate medical students of Gujarat. International Journal of Pharmaceutical Sciences and Research. 2012 May 1;3(5):1511.

Anuradha CR, Komathi J, Subashree A. A cross-sectional study on the knowledge, attitude, and practices of pharmacovigilance among healthcare professionals at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol 2020;10(08):682-687.

Khan Z, Karatas Y, Hamid SM. Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study. PLoS One. 2023 May 24;18(5):e0285811. doi: 10.1371/journal.pone.0285811. PMID: 37224133; PMCID: PMC10208525.

Srinivasan V, Sheela D, Mridula D. Knowledge, attitude and practice of pharmacovigilance among the healthcare professionals in a tertiary care hospital–A questionnaire study. Biomedical & Pharmacology Journal. 2017;10(3):1441-7.

Datta S, Sengupta S. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting in a tertiary care teaching hospital of Sikkim. PerspectClin Res. 2015 Oct-Dec;6(4):200-6. doi: 10.4103/2229-3485.167096. PMID: 26623391; PMCID: PMC4640013.

Adithan C. A survey on knowledge, attitude, and practice of pharmacovigilance towards adverse drug reactions reporting among doctors and nurses in a tertiary care hospital in South India. Journal of Young Pharmacists. 2016;8(4):471.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes, and perceptions amongst resident doctors. Journal of pharmaceutical sciences and research. 2011 Feb 1;3(2):1064.

Hardeep, Bajaj JK, Rakesh K. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India. J ClinDiagn Res. 2013 Jan;7(1):97-9. doi 10.7860/JCDR/2012/4883.2680. Epub 2012 Oct 20. PMID: 23449824; PMCID: PMC3576761.

Gupta R, Malhotra A, Malhotra P. A study on determinants of underreporting of adverse drug reactions among resident doctors. Int J Res Med Sci 2018;6:623-7.

Rishi RK, Patel RK, Bhandari A. Under-reporting of ADRs by medical practitioners in India—results of a pilot study. AdvPharmacoepidem Drug Saf. 2012;1(3):112.

Singh, S. R., D. Khanikar, P. P. Saikia, and D. Devi. “TO ASSESS THE KNOWLEDGE, ATTITUDE, AND PRACTICE OF PHARMACOVIGILANCE AND ADVERSE DRUG REACTION REPORTING AMONG THE UNDERGRADUATE AND POSTGRADUATE MEDICAL STUDENTS IN A TERTIARY CARE TEACHING HOSPITAL IN ASSAM: A QUESTIONNAIRE-BASED STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 5, May 2023, pp. 70-75, doi:10.22159/ajpcr.2023.v16i5.47180.

ARUN, S., R. ASHALATHA, B. S. B. MALLIKA, S. S. SONIA, M. SAGARIKA, and . M. T. S. PRIYA. “ASSESSMENT OF KNOWLEDGE, ATTITUDE AND PRACTICE (KAP) OF NUTRIVIGILANCE AMONG PHASE-2 MBBS AND POSTGRADUATE STUDENTS OF A TERTIARY CARE HOSPITAL CROSS-SECTIONAL OBSERVATIONAL STUDY”. International Journal of Current Pharmaceutical Research, vol. 16, no. 2, Mar. 2024, pp. 32-37, doi:10.22159/ijcpr.2024v16i2.4025.